Annual Net Income
-$30.44 M
+$37.50 M+55.19%
December 31, 2023
Summary
- As of February 7, 2025, PRQR annual net profit is -$30.44 million, with the most recent change of +$37.50 million (+55.19%) on December 31, 2023.
- During the last 3 years, PRQR annual net income has risen by +$22.74 million (+42.76%).
- PRQR annual net income is now -604.62% below its all-time high of -$4.32 million, reached on December 31, 2013.
Performance
PRQR Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$8.92 M
-$6.02 M-207.64%
September 1, 2024
Summary
- As of February 7, 2025, PRQR quarterly net profit is -$8.92 million, with the most recent change of -$6.02 million (-207.64%) on September 1, 2024.
- Over the past year, PRQR quarterly net income has dropped by -$2.70 million (-43.43%).
- PRQR quarterly net income is now -3462.48% below its all-time high of $265.20 thousand, reached on March 31, 2015.
Performance
PRQR Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$26.04 M
-$2.70 M-11.57%
September 1, 2024
Summary
- As of February 7, 2025, PRQR TTM net profit is -$26.04 million, with the most recent change of -$2.70 million (-11.57%) on September 1, 2024.
- Over the past year, PRQR TTM net income has increased by +$12.09 million (+31.70%).
- PRQR TTM net income is now -2142.59% below its all-time high of -$1.16 million, reached on September 30, 2013.
Performance
PRQR TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
PRQR Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +55.2% | -43.4% | +31.7% |
| 3 y3 years | +42.8% | +62.0% | +64.7% |
| 5 y5 years | +30.1% | +62.0% | +64.7% |
PRQR Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +57.6% | -207.6% | +62.0% | -11.6% | +64.7% |
| 5 y | 5-year | at high | +57.6% | -207.6% | +62.0% | -11.6% | +64.7% |
| alltime | all time | -604.6% | +57.6% | -3462.5% | +62.0% | -2142.6% | +64.7% |
ProQR Therapeutics NV Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.92 M(+207.6%) | -$26.04 M(+11.6%) |
| Jun 2024 | - | -$2.90 M(-65.2%) | -$23.34 M(-20.0%) |
| Mar 2024 | - | -$8.32 M(+40.9%) | -$29.16 M(-4.2%) |
| Dec 2023 | -$30.44 M(-55.2%) | -$5.90 M(-5.0%) | -$30.43 M(-20.2%) |
| Sep 2023 | - | -$6.22 M(-28.7%) | -$38.12 M(-31.2%) |
| Jun 2023 | - | -$8.72 M(-9.2%) | -$55.40 M(-9.6%) |
| Mar 2023 | - | -$9.59 M(-29.4%) | -$61.27 M(-9.2%) |
| Dec 2022 | -$67.94 M(-5.5%) | -$13.60 M(-42.1%) | -$67.51 M(-8.5%) |
| Sep 2022 | - | -$23.49 M(+61.0%) | -$73.75 M(+8.5%) |
| Jun 2022 | - | -$14.59 M(-7.8%) | -$68.00 M(-6.1%) |
| Mar 2022 | - | -$15.83 M(-20.2%) | -$72.38 M(+0.9%) |
| Dec 2021 | -$71.87 M(+35.1%) | -$19.83 M(+11.8%) | -$71.74 M(+6.0%) |
| Sep 2021 | - | -$17.74 M(-6.5%) | -$67.67 M(+3.6%) |
| Jun 2021 | - | -$18.98 M(+24.9%) | -$65.34 M(+28.4%) |
| Mar 2021 | - | -$15.19 M(-3.6%) | -$50.89 M(-4.7%) |
| Dec 2020 | -$53.18 M(-15.9%) | -$15.76 M(+2.2%) | -$53.42 M(-8.2%) |
| Sep 2020 | - | -$15.41 M(+240.4%) | -$58.18 M(+3.4%) |
| Jun 2020 | - | -$4.53 M(-74.4%) | -$56.27 M(-13.2%) |
| Mar 2020 | - | -$17.72 M(-13.7%) | -$64.83 M(+2.6%) |
| Dec 2019 | -$63.23 M | -$20.52 M(+52.1%) | -$63.19 M(+10.1%) |
| Sep 2019 | - | -$13.50 M(+3.1%) | -$57.41 M(+12.9%) |
| Jun 2019 | - | -$13.09 M(-18.6%) | -$50.84 M(+9.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$16.08 M(+9.1%) | -$46.52 M(+6.9%) |
| Dec 2018 | -$43.56 M(-11.8%) | -$14.74 M(+112.7%) | -$43.53 M(+3.5%) |
| Sep 2018 | - | -$6.93 M(-21.0%) | -$42.08 M(-11.4%) |
| Jun 2018 | - | -$8.77 M(-33.1%) | -$47.50 M(-7.3%) |
| Mar 2018 | - | -$13.09 M(-1.4%) | -$51.24 M(+3.9%) |
| Dec 2017 | -$49.42 M(+14.2%) | -$13.29 M(+7.5%) | -$49.31 M(+8.3%) |
| Sep 2017 | - | -$12.36 M(-1.2%) | -$45.54 M(+2.4%) |
| Jun 2017 | - | -$12.50 M(+12.0%) | -$44.48 M(+2.9%) |
| Mar 2017 | - | -$11.16 M(+17.3%) | -$43.23 M(-0.2%) |
| Dec 2016 | -$43.28 M(+87.2%) | -$9.51 M(-15.8%) | -$43.32 M(+6.9%) |
| Sep 2016 | - | -$11.30 M(+0.5%) | -$40.51 M(+11.8%) |
| Jun 2016 | - | -$11.25 M(+0.0%) | -$36.22 M(+5.0%) |
| Mar 2016 | - | -$11.25 M(+67.8%) | -$34.50 M(+50.1%) |
| Dec 2015 | -$23.12 M(+43.3%) | -$6.70 M(-4.5%) | -$22.99 M(+22.1%) |
| Sep 2015 | - | -$7.02 M(-26.3%) | -$18.83 M(+15.6%) |
| Jun 2015 | - | -$9.53 M(-3693.6%) | -$16.28 M(+22.1%) |
| Mar 2015 | - | $265.20 K(-110.4%) | -$13.33 M(-17.8%) |
| Dec 2014 | -$16.13 M(+273.3%) | -$2.54 M(-43.1%) | -$16.22 M(+2.0%) |
| Sep 2014 | - | -$4.47 M(-32.0%) | -$15.90 M(+26.3%) |
| Jun 2014 | - | -$6.58 M(+150.2%) | -$12.59 M(+109.4%) |
| Mar 2014 | - | -$2.63 M(+18.2%) | -$6.01 M(+77.7%) |
| Dec 2013 | -$4.32 M | -$2.22 M(+91.6%) | -$3.39 M(+191.6%) |
| Sep 2013 | - | -$1.16 M | -$1.16 M |
FAQ
- What is ProQR Therapeutics NV annual net profit?
- What is the all time high annual net income for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV annual net income year-on-year change?
- What is ProQR Therapeutics NV quarterly net profit?
- What is the all time high quarterly net income for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV quarterly net income year-on-year change?
- What is ProQR Therapeutics NV TTM net profit?
- What is the all time high TTM net income for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV TTM net income year-on-year change?
What is ProQR Therapeutics NV annual net profit?
The current annual net income of PRQR is -$30.44 M
What is the all time high annual net income for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high annual net profit is -$4.32 M
What is ProQR Therapeutics NV annual net income year-on-year change?
Over the past year, PRQR annual net profit has changed by +$37.50 M (+55.19%)
What is ProQR Therapeutics NV quarterly net profit?
The current quarterly net income of PRQR is -$8.92 M
What is the all time high quarterly net income for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high quarterly net profit is $265.20 K
What is ProQR Therapeutics NV quarterly net income year-on-year change?
Over the past year, PRQR quarterly net profit has changed by -$2.70 M (-43.43%)
What is ProQR Therapeutics NV TTM net profit?
The current TTM net income of PRQR is -$26.04 M
What is the all time high TTM net income for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high TTM net profit is -$1.16 M
What is ProQR Therapeutics NV TTM net income year-on-year change?
Over the past year, PRQR TTM net profit has changed by +$12.09 M (+31.70%)